Trials / Completed
CompletedNCT00334022
Fuzeon Viral Decay Pilot Study
A Pilot Randomized Controlled Trial of Adding Enfuvirtide to Standard Combination Antiretroviral Therapy in HIV-infected Individuals With Full Virologic Suppression to Further Suppress Proviral HIV DNA
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 18 (actual)
- Sponsor
- Canadian Immunodeficiency Research Collaborative · Academic / Other
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
In order to better understand the source(s) and the mechanism(s) of HIV persistence and to potentially lead to further suppression of HIV from viral reservoirs, we propose to examine the effect of co-administration of enfuvirtide, an entry inhibitor of HIV, on diminution of the size of the viral reservoir in infected individuals who are receiving effective antiviral therapy for extended periods of time (\> 5 years).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | enfuvirtide | 1ml BID |
Timeline
- Start date
- 2006-02-01
- Primary completion
- 2007-07-01
- Completion
- 2010-01-01
- First posted
- 2006-06-06
- Last updated
- 2012-06-05
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT00334022. Inclusion in this directory is not an endorsement.